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DObjective:We describe a method to measure oxygen consumption (VO2) and pulmonary vascular resistive in-
dex (PVRI) based on thermodilution cardiac output in patients with complex mixing circulations. We apply this
method to patients with a bidirectional cavopulmonary anastomosis (BDCPA). We compare our measured VO2
with a predicted VO2 based on a formula using height and weight.
Methods:We reviewed data based on cardiac catheterization and thermodilution cardiac output in a series of 25
catheterizations in patients with BDCPA. We used this data to measure VO2 and PVRI, and looked for a corre-
lation between the predicted and measured VO2. We also assessed whether any other hemodynamic parameter
correlated with measured VO2.
Results: There was no significant correlation between the predicted and the measured VO2 (correlation
coefficient ¼ 0.258, P ¼ .21). We did find a significant correlation in the difference between the measured
and predicted VO2 against the measured VO2 such that at a lower measured VO2 the predictive formula tended
to overestimate VO2 and at a higher VO2 the formula underestimated VO2 (correlation coefficient ¼ 0.963,
P<.0001). Body surface area did not correlate with measured VO2 (correlation coefficient ¼ 0.28, P<.16).
Mixed venous oxygen content showed a weak negative correlation with VO2 (correlation coefficient ¼ 0.54,
P ¼ .005).
Conclusions: An assessment of PVRI that is based on a predicted VO2 is unreliable in this patient population.
No hemodynamic parameter correlated well with VO2. The use of a measured VO2 is necessary in determining
PVRI in these patients. (J Thorac Cardiovasc Surg 2013;146:1179-84)The assessment of pulmonary blood flow and pulmonary
vascular resistance (PVR) in complex mixing circulations
is challenging. Still, this assessment remains an important
aspect in risk stratification prior to staged surgical palliation
via bidirectional cavopulmonary anastomosis (BDCPA)
and the Fontan procedure. Typically, this assessment is
done by combining cardiac catheterization data with the
use of a predicted oxygen consumption (VO2) from one
of several predictive formulas because methods of direct
measurement of VO2 are complicated and require expensive
equipment and operator expertise.
We report a previously undescribed method of calculat-
ing PVR and VO2. We compare this measured VO2 with
a standard predicted VO2 based on the formula described
by Krovets and Goldbloom.1 We demonstrate how we can
calculate PVR based on thermodilution cardiac outpute Department of Pediatric Cardiology, Dalhousie University, Halifax, Nova
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The Journal of Thoracic and Carstudies in patients with BDCPA. This method can be used
in many complex mixing circulations to calculate flows
and resistances in the systemic or pulmonary vascular
beds. We examined hemodynamic parameters that might
predict VO2 in BDCPA.METHODS
Assessing the Pulmonary Vascular Resistive Index
(PVRI)
Assessment of PVR in a normal circulation is based on the application
of Ohm’s law:
PVR ¼ DP=QP;
where R is resistance, DP is the mean transpulmonary pressure gradient,
and QP is pulmonary blood flow.
Pressure is obtained by direct measurement. Pulmonary blood flow
equals VO2 divided by the difference in oxygen content please insert
‘‘(cO2)’’ in the pulmonary veins and in the main pulmonary artery:
QP ¼ VO2=ðcO2 PV  cO2 PAÞ;
where cO2 is the content of oxygen, PV is the pulmonary vein, and PA is the
pulmonary artery.
VO2 can be measured using indirect calorimetry with a Douglas bag, or
with tandem mass spectrometry. These methods measure the inspired and
expired oxygen content directly, but they are time-consuming, and many
centers do not have tandem mass spectrometry to perform such measure-
ments. Oxygen consumption can also be predicted using one of a number
of formulas, including those by Lafarge and Miettinen,2 Lundell anddiovascular Surgery c Volume 146, Number 5 1179
Abbreviations and Acronyms
Ao ¼ aortic
APC ¼ aortopulmonary collateral
BDCPA ¼ bidirectional cavopulmonary
anastomosis
BSA ¼ body surface area
cO2 ¼ content of oxygen
DP ¼ mean transpulmonary pressure gradient
IVC ¼ inferior vena cava
MRI ¼ magnetic resonance imaging
RA ¼ right atrium
PA ¼ pulmonary artery
PV ¼ pulmonary vein
PVR ¼ pulmonary vascular resistance
PVRI ¼ pulmonary vascular resistive index
QP ¼ pulmonary blood flow
QS ¼ cardiac output
QV ¼ systemic ventricular output
SVC ¼ superior vena cava
VcO2 ¼ minute oxygen delivery
VO2 ¼ oxygen consumption
Congenital Heart Disease Schantz and Chen
C
H
Dcolleagues,3 Lindahl,4 Wessel and associates,5 and Krovets and Gold-
bloom.1 A predictive formula for VO2 does not require complex measure-
ments, which makes them an attractive solution for obtaining VO2.
However, it has been shown that these formulas are unreliable when com-
pared with measured VO2 in children with congenital heart defects.
Laitinen and Rasanen,6 who compared the formulas by Lindahl,4Wessel
and associates,5 Lundell and colleagues,3 against indirect calorimetry, and
Li and coworkers,7 who compared the same formulas as well as the formula
published by Lafarge andMiettinen2 against respiratory mass spectrometry
in childrenwith congenital heart disease found the predictive formulas to be
unreliable. In the latter study, the predictive formulas were found to overes-
timate lower and underestimate higher indexed VO2. Likewise, Shanahan
and colleagues8 compared the predictive formulas by Lindahl,4 Lundell
and colleagues,3 and Lafarge and Miettinen2 against indirect calorimetry
in 35 patients with a BDCPA. They found that the formulas overestimated
VO2 in their patients and led to an underestimation of PVR, resulting in
errors in risk stratification for these patients.
Minute Oxygen Delivery
The search for a simple, noninvasive measurement of cardiac output is
ongoing.9 Invasivemeasurement by thermodilution studies are possible and
require little additional time or expense for patients who are undergoing
planned cardiac catheterization. Thermodilution-derived measurements
of cardiac output have generally been found to have good agreement
compared with Fick-derived measurements of cardiac output.9-11
In simple circulations without intracardiac shunts, it is possible to mea-
sure cardiac output with thermodilution studies. In this case, pulmonary
blood flow is equal to cardiac output (QP ¼ QS); therefore, QP is measured
directly and PVR can be solved without measuring VO2. In this circum-
stance, VO2 can be calculated using the Fick principle:
VO2 ¼ QP3ðcO2 PV  cO2 PAÞ
In BDCPA, it is possible to measure systemic ventricular output (QV) us-
ing thermodilution cardiac output studies, but QV is not equal to QP . To1180 The Journal of Thoracic and Cardiovascular Surresolve this problem, we introduce the concept of minute oxygen delivery
(VcO2).
Oxygen contents and saturations are not additive. In the case of
a BDCPA, it is not possible to calculate the aortic (Ao) cO2 or saturation
based on the oxygen contents and saturations in the right atrium (RA)
and PVs. Oxygen content in the aorta depends on both the flow and the
cO2 from each of the sources. If we multiply the cO2 in a vessel (measured
in mL/L) by the flow through the vessel (measured in L/min), we obtain the
VcO2 through the vessel (measured in mL O2/min). We designate this min-
ute oxygen delivery as VcO2.
Therefore, in a BDCPA, where U is upper body, L is upper body, QEP is
effective pulmonary blood flow, x is the thermodilution measurement.
VcO2 Ao ¼ VcO2 PV þ VcO2 RA
QV ¼ QU þ QL
QU ¼ QEP
QV ¼ QEP þ QL
QL ¼ QV  QEP
QV ¼ x
QV 3 cO2 AO ¼ QEP 3 cO2 PV þ QL3 cO2 RA
QV 3 cO2 AO ¼ QEP 3 cO2 PV þ ðQV  QEPÞ 3 cO2 RA
QEP ¼
x 3 ðcO2 AO  cO2 RAÞ
ðcO2 PV  cO2 RAÞ
Then,
QEP ¼
VO2
ðcO2 PV  cO2 PAÞ
VO2 ¼ x 3 ðcO2 AO  cO2 RAÞ3ðcO2 PV  cO2 PAÞðcO2 PV  cO2 RAÞ
Using this method, certain considerations apply to the collection and
interpretation of samples during the cardiac catheterization. There should
be no competitive blood flow into the PA, including large aortopulmo-
nary collaterals (APCs) or antegrade flow through a patent pulmonary
valve. Right atrial blood sampling should be done near the RA–inferior
vena cava (IVC) junction to minimize admixture from the PVs, but still
allow adequate mixture of blood from the lower body. The PV sample
ideally should contain mixed PV blood, but not contain admixture
from the IVC.Subjects
We gathered data prospectively from cardiac catheterizations done in
patients with BDCPA from September 2000 to March 2009. We included
data sets from multiple catheterizations in the same patient as long as
they were done>12 months apart. We excluded those patients with com-
petitive blood supply from the PAwhen it had not been ligated, such as pa-
tients with tricuspid atresia who still had antegrade flow through the
pulmonary valve.Catheterization Procedure
All catheterizations were done under general anesthesia with mechani-
cal, positive-pressure ventilation. Hemodynamic data were collected at thegery c November 2013
FIGURE 1. The relationship between the difference in measured and pre-
dicted oxygen consumption (VO2) against predicted VO2. No difference
would be represented as a horizontal scattering around 0 (Pearson correla-
tion coefficient ¼ 0.96, P<.001).
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Dbeginning of the catheterization followed by thermodilution cardiac output
studies and prior to any angiography. A thermodilution catheter was used to
inject room-temperature saline into the IVC or RA with the thermistor in
the ascending aorta. We repeated injections until we had 3 samples that
were within 10%, and used the averaged value for cardiac output.
Measured VO2 and PVR were determined using the method described
earlier. Predicted VO2 was calculated using the formula by Krovetz and
Goldbloom1:
VO2 ¼ 1:39 3 Height þ 0:84 3Weight  35:7;
where height is measured in centimeters and weight is measured in
kilograms.
Data Analysis
We looked for correlation between measured and predicted VO2
(indexed and nonindexed). We also looked for correlation between the dif-
ference in the predicted andmeasured VO2 against themeasuredVO2. Last,
we looked for correlations between patient variables such as height, weight,
and body surface area (BSA) as well as hemodynamic parameters includ-
ing cO2 and mean pressures throughout the circulation against the mea-
sured VO2. We evaluated whether there was a parameter that could be
a surrogate for VO2 measurement with thermodilution cardiac output.
We used the Pearson 2-tailed test to look for correlation coefficients be-
tween variables. Results were considered statistically significant if the
P value was<.05.
This study was donewith the approval of the research ethics board at the
IWKHealth Centre. Because of the nature of the study, the requirement for
informed consent was waived.TABLE 1. Correlation between hemodynamic parameters and
indexed VO2
Variable Pearson correlation coefficient (P value)
QV 0.09 (.65)
QV, indexed 0.16 (.42)
TcO2 RA 0.54 (.005)
TcO2 PV 0.37 (.07)
TcO2 SVC 0.39 (.049)
TcO2 Ao 0.37 (.07)
RAP 0.02 (.9)
mPAP 0.04 (.85)
VEDP 0.07 (.72)
QV, Thermodilution cardiac output; TcO2, total content of oxygen; RA, right atrium;
PV, pulmonary vein; SVC, superior vena cava; Ao, aorta; mPAP, mean pulmonary
arterial pressure; VEDP, ventricular end diastolic pressure.RESULTS
Twenty-seven catheterizations were included. Two pa-
tients were excluded from the analysis because of compet-
itive pulmonary blood flow via a patent pulmonary valve.
This left 25 catheterizations from 21 patients. The age range
was 1.3 to 10 years of age at the time of cardiac catheteri-
zation, with a median age of 2.9 years.
The systemic ventricle was the morphologically right
ventricle in 11 patients (52%) and the morphologically
left ventricle in 10 patients (48%). The underlying cardiac
malformation was pulmonary atresia with intact ventricular
septum in 3 patients (14%), double-inlet left ventricle in 7
patients (33%), atrioventricular septal defect in 2 patients
(10%), hypoplastic left heart syndrome in 6 patients
(29%), and dextrocardia, atrioventricular septal defect
with heterotaxy in 3 patients (14%).
Fifteen of 21 patients (67%) had collateralization identi-
fied at the time of cardiac catheterization. Nine patients
(43%) had APCs and 10 patients (48%) had venovenous
collaterals, with 4 patients having both APCs and venove-
nous collaterals. The majority of these were hemodynami-
cally insignificant or were venovenous and did not
contribute to any unmeasured shunt. Two patients under-
went coil occlusion of collateral vessels; one was a small,
left-sided superior vena cava (SVC) and the other was
a large APC off of an internal mammary artery.
We found there was no correlation between the
predicted VO2 and the measured VO2 (correlationThe Journal of Thoracic and Carcoefficient ¼ 0.26, P ¼ .21). We did find correlation be-
tween the difference in the predicted and the measured
VO2 compared with the measured VO2 (Figure 1). The Kro-
vets and Goldbloom1 equation increasingly overestimated
VO2 as the measured VO2 diminished. An overestimation
of VO2 results in an underestimation in PVR.
There were no hemodynamic parameters that were
a good substitute for measuring VO2. We did see a weak,
but significantly negative, correlation between the cO2 in
the RA and the SVC against the VO2 (Table 1). We found
that as VO2 increased, the systemic venous cO2 decreased.
As expected, there is a high correlation between the Kro-
vets and Goldbloom1 predicted VO2 and BSA (correlation
coefficient ¼ 0.96, P<.001), because this value is calcu-
lated from the same parameters as BSA. However, our
measured VO2 from thermodilution cardiac outputdiovascular Surgery c Volume 146, Number 5 1181
FIGURE 2. Therewas no correlation between body surface area andmea-
sured oxygen consumption (Pearson correlation coefficient ¼ 0.02,
P ¼ .211).
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coefficient ¼ 0.28, P<.16; Figure 2).DISCUSSION
The Fontan operation is the final stage in a series of op-
erations creating a circuit to route systemic venous return
passively to the PAs, so a single ventricle provides systemic
output. It is used to palliate a number of complex congenital
heart defects in which a biventricular circulation cannot be
attained.
The Fontan operation is preceded by a BDCPA in which
the SVC is connected to the PAs. Choussat and Fontan out-
lined 10 criteria, which have become known as the 10 Com-
mandments, to ensure a good outcome for the Fontan
procedure.12 These are essentially a mean pulmonary arte-
rial pressure of<15 to 20 mm Hg and a normal PVRI.13,14
There has been controversy over the necessity of cardiac
catheterization for risk assessment prior to the Fontan pro-
cedure with the availability of magnetic resonance imaging
(MRI) to provide good anatomic assessment of cardiac and
pulmonary arterial anatomy.15,16 However, catheterization
remains the only way to assess PVRI, pulmonary arterial
pressure, transpulmonary gradient, and ventricular end
diastolic pressure, which are all predictive of outcome.
Mair and colleagues17 developed an index based on PVR
and ventricular end diastolic pressure. They evaluated this
index as a predictor of mortality in children with tricuspid
atresia undergoing the Fontan procedure. They found an in-
dex of<4 was associated with an 8% late mortality whereas
an index>4 was associated with a late mortality of 39%.
Pizzaro and associates18 reported the outcomes of their
patient population of 107 children aged 11 to 35 months1182 The Journal of Thoracic and Cardiovascular Surundergoing the Fontan procedure with both single right
and single left ventricular anatomy. They reported a trans-
pulmonary gradient of 7.2  1.5 mm Hg in those who
died compared with 5.3  1.9 (P ¼ .03) in survivors. Ele-
vated pulmonary arterial pressures also predicted a higher
likelihood of Fontan takedown.
Malhotra and coworkers19 reviewed the results of 52 Fon-
tan procedures in patients with systemic left or right ventri-
cles. They found that an elevated PVRI was predictive of
Fontan failure resulting in death, revision or takedown of
the Fontan, or cardiac transplant. The PVRI in the group
that failed with the Fontan procedure was 2.43  1.01
Woods units, which is significantly higher than the overall
group (1.95  1.42 [P ¼ .007]). This study was performed
in Denver, Colorado, with patients living at high altitudes.
Therefore, although the finding of an increased PVRI in
this group is important, the specific PVRI probably cannot
be generalized to other populations. Other authors have
found increased PVR to correlate with longer duration of
pleural effusion.20
Our data confirm that using an estimated VO2 for calcu-
lation of PVR introduces error. The majority of our patients
had a measured VO2 that was lower than their predicted
VO2. Because all our patients were about the same age at
the time of their catheterizations, the predicted VO2 based
on the Krovetz and Goldbloom1 formula tended to be
very similar between patients. This explains why there
was a nearly linear relationship between the difference in
predicted and measure VO2 versus the measured VO2.
As seen in Figure 1, the predicted VO2 was almost always
greater than the measured VO2. Because the calculation of
PVR is based on pressure divided by flow, and flow is pro-
portional to VO2 using the Fick principle, an erroneously
high VO2 results in a systematic underestimation of PVR.
This has also been shown to be the case in other studies
that have examined the effect of using an estimated VO2
versus a measured VO2.
6,8
We also show that there is no hemodynamic parameter
that can be substituted for direct measurement of VO2. Al-
though there was correlation with cO2 in the RA and SVC
against the indexed-measured VO2, this correlation proba-
bly tells usmore about how the body responds in low cardiac
output situations. Again, using the Fick principle
(VO2¼ Qv3 (cO2Ao cO2SV) a decrease in cO2SV repre-
sents more oxygen extraction. If cardiac output is relatively
fixed, the only way to increase VO2 is to increase oxygen ex-
traction at the tissue level, resulting in a lower venous O2.
We did not find correlation between themeasuredVO2 and
BSA, as was present when we looked at the Krovetz and
Goldbloom1 prediction of VO2 against BSA. Prediction of
VO2 based on height and weight is clearly oversimplified be-
cause it is influenced by other variables. Li and colleagues21
demonstrated that increases arterial in arterial partial pressure
of carbon dioxide (PaCO2) from 35 to 55 mm Hg resulted ingery c November 2013
Schantz and Chen Congenital Heart Disease
C
H
Da significant decrease in VO2 from 146 mL/min/m
2 to 126
mL/min/m2 in postoperative BDCPA patients.
The formula by Lafarge and Miettinen2 attempts to com-
pensate for some of those variables with the incorporation
of heart rate into its predictive formula. We did not record
heart rate prospectively at the time of our data acquisition,
and its retrospective assessment is not possible because
heart rate can vary significantly, even under general anes-
thesia. However, this formula has been shown to underesti-
mate VO2 when evaluated in this patient population.
8
The results of our comparison of a measured VO2 by ther-
modilution cardiac output to a predicted VO2 by Krovets
and Goldbloom1 were similar to the results of a comparison
by Li and colleagues7 between measured VO2 by respira-
tory mass spectrometry with 4 predictive formulas (Lin-
dahl,4 Wessel and associates,5 Lundell and colleagues,3
and Lafarge and Miettinen2). Their study was performed
in ventilated children with congenital heart disease. Both
studies demonstrate that the predictive formulas tend to
overestimate lower VO2 and underestimate higher VO2
(Figure 1). In our study, we excluded patients with large
APCs from our assessment. It is well known that APCs
are often present, and it is difficult to quantify APC flow an-
giographically. Grosse-Wortmann and colleagues22 re-
cently demonstrated the quantification of APC flow by
MRI. They found that APC flow contributed as much as
46% of QP in patients with a BDCPA as measured by
MRI. Although this may seem problematic, our formula de-
rives QP based on pulmonary venous cO2 so that APC flow
is accounted for. As such, APC flow is not a concern in as-
sessing QP. Potential for error remains, however, if the mea-
sured pulmonary venous cO2 has been altered by flow from
a systemic vein to a pulmonary venous connection or re-
gional pulmonary disease.
It should be noted that the thermodilution method must
be applied with caution in patients with severe atrioventric-
ular or aortic valve regurgitation. Although some studies
have failed to find an effect on thermodilution-derived car-
diac output compared with the Fick method in patients with
severe tricuspid valve regurgitation,23 other studies have
found that the thermodilution method underestimates car-
diac output in this situation.24-26 None of our patients had
more than moderate valvar regurgitation. However, one
must keep in mind that if this method is applied in
patients with significant valvar regurgitation, a potential
source of error is introduced.
One final potential limitation of this technique is that it in
these circulations, it is not possible to obtain a pure systemic
or pulmonary venous oxygen saturation. We attempted to
overcome this with careful positioning of the sampling
catheter, as described earlier. Specifically, the pulmonary
venous sample was taken from a posterior location in the
pulmonary venous atrium, close to the orifice of the PVs,
to sample only pulmonary venous return. In our series,The Journal of Thoracic and Carthe pulmonary venous saturations were all 95% or more,
suggesting little systemic venous contamination. However,
contamination of systemic or pulmonary venous samples
should be regarded as another potential source of error
when using this method.CONCLUSIONS
The reliance on an estimated VO2 in the assessment of
PVR in patients with BDCPA prior to the Fontan operation
provides erroneous results. The method presented for calcu-
lating VO2 is simple and can be done in centers where other
methods of measuring VO2 directly are not readily avail-
able, by incorporating thermodilution cardiac output as
part of the routine pre-Fontan cardiac catheterization. In
this era, there are few instances when the Fontan procedure
is not offered on the basis of risk. However, it remains useful
to assess patients’ risk and to evaluate outcomes in relation
to their risk. Because assessing PVR remains one of the pri-
mary reasons for cardiac catheterization in this group of pa-
tients, this method provides a more precise assessment of
PVR and can be used with ease.
We thank Colleen O’Connell, PhD, from the IWK Perinatal
Epidemiology Research Unit, for her assistance with statistical
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